Literature DB >> 11471293

[MR angiography in diagnosis of vasculitis and benign angiopathies of the central nervous system].

A Schlüter1, W Hirsch, A Jassoy, M Kornhuber, C Behrmann, G Keysser, R P Spielmann.   

Abstract

PURPOSE: To evaluate TOF 3D magnetic resonance angiography (MRA) of the intracranial arteries in patients with vasculitis or vasculitis-like benign angiopathy of the central nervous system (CNS).
METHOD: The results of MRA in 20 patients with clinically and radiographically proven vasculitis (17/20) or vasculitis-like benign angiopathy (3/20) of the CNS were retrospectively analysed. Patients with hyperintense lesions of more than 3 mm on T2-weighted MRI images were included in this trial. An inflammatory, embolic, neurodegenerative or metastatic origin of these lesions was excluded by extensive clinical studies. For the MR-examination a TOF 3D FISP sequence was used on a 1.5 T imager.
RESULTS: MRA showed characteristic changes for vasculitis or angiopathy in 15 of 20 patients (75%).
CONCLUSIONS: In patients suspected of having a vasculitis or vasculitis-like angiopathy, MRA is recommended as a non-invasive modality. If the results of MRI and extensive clinical studies are carefully correlated, MRA may substitute conventional angiography in cases with typical vascular changes.

Entities:  

Mesh:

Year:  2001        PMID: 11471293     DOI: 10.1055/s-2001-14995

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  3 in total

1.  Varicella-zoster vasculitis presenting with intracranial hemorrhage.

Authors:  Rajan Jain; John Deveikis; Susan Hickenbottom; Suresh K Mukherji
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

Review 2.  MR angiography of the intracranial vessels: technical aspects and clinical applications.

Authors:  Ozkan Ozsarlak; Johan W Van Goethem; Menno Maes; Paul M Parizel
Journal:  Neuroradiology       Date:  2004-12-04       Impact factor: 2.804

3.  Magnetic resonance angiography in suspected cerebral vasculitis.

Authors:  Philippe Demaerel; Nele De Ruyter; Frederik Maes; Beatrijs Velghe; Guido Wilms
Journal:  Eur Radiol       Date:  2004-02-10       Impact factor: 5.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.